NATCO Pharma Limited
NSE: NATCOPHARM · Healthcare
₹866.25
-17.80 (-2.01%)
Last close · 30 Aug 2026, 11:55 am IST
- Open
- ₹884.00
- Day high
- ₹885.05
- Day low
- ₹865.00
- Volume
- 4.43 L
- Prev close
- ₹884.05
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty PharmaNifty Smallcap 100Nifty Smallcap 250Nifty Smallcap 50
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 16,504 Cr
- Price
- 921.45
- P/E (TTM)
- 11.63
- P/E (Fwd)
- 20.12
- P/B
- 1.79
- EV/EBITDA
- 10.50
- EV/Revenue
- 3.70
- PEG
- —
- Div Yield
- 0.71%
- 52W High
- 1,226.80
- 52W Low
- 789.00
- Beta
- 0.20
Profitability & income
- Revenue (TTM)
- 4,078 Cr
- Net Income (TTM)
- 1,418 Cr
- EBITDA
- 1,436 Cr
- Gross Margin
- 83.07%
- Op. Margin
- 10.44%
- Net Margin
- 34.78%
- ROE
- 16.85%
- ROA
- 7.80%
- EPS (TTM)
- 79.24
- EPS (Fwd)
- 45.80
Financial health
- Total Debt
- 714 Cr
- Total Cash
- 2,129 Cr
- Debt/Equity
- 7.74
- Current Ratio
- 3.01
- Quick Ratio
- 1.79
- Book Value
- 514.92
- Free Cash Flow
- 821 Cr
- Op. Cash Flow
- 1,768 Cr
Growth
- Revenue Growth
- -39.60%
- Earnings Growth
- -34.10%
- Earnings QoQ
- -34.10%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 739 Cr | 268 Cr | 205 Cr | 77 Cr | 584 Cr | — | 714 Cr | 9,221 Cr |
| 2025-12-31 | 647 Cr | 152 Cr | 217 Cr | 113 Cr | 514 Cr | — | — | — |
| 2025-09-30 | 1,363 Cr | 518 Cr | 679 Cr | 527 Cr | 1,193 Cr | — | 261 Cr | 8,650 Cr |
| 2025-06-30 | 1,329 Cr | 481 Cr | 633 Cr | 513 Cr | 1,096 Cr | — | — | — |
| 2025-03-31 | 1,221 Cr | 407 Cr | 614 Cr | 450 Cr | 972 Cr | — | 279 Cr | 7,607 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4,078 Cr | 1,419 Cr | 1,734 Cr | 1,230 Cr | 3,388 Cr | 1,768 Cr | 714 Cr | 9,221 Cr |
| 2025-03-31 | 4,430 Cr | 1,885 Cr | 2,551 Cr | 1,961 Cr | 3,740 Cr | 1,697 Cr | 279 Cr | 7,607 Cr |
| 2024-03-31 | 3,979 Cr | 1,388 Cr | 1,872 Cr | 1,577 Cr | 3,116 Cr | 1,212 Cr | 371 Cr | 5,853 Cr |
| 2023-03-31 | 2,697 Cr | 715 Cr | 1,035 Cr | 790 Cr | 1,951 Cr | 849 Cr | 176 Cr | 4,874 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for NATCOPHARM?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in